AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Zynesp 40 Injection

Prescription Icon
Prescription Required

Marketer

Zydus Cadila

Salt Composition

Darbepoetin alfa (40mcg)

Overview Zynesp 40 Injection

Darbepoetin alfa 40mcg Injection treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves boosting red blood cell production in the bone marrow. This medication requires careful administration due to potential serious adverse effects. Treatment should be overseen by a physician experienced in its use, with strict adherence to their instructions. Administered under medical supervision, common side effects include abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral swelling. Report symptoms of severe hypertension, such as intense headache, visual disturbances, nausea, vomiting, or convulsions, immediately. Regular blood tests monitoring electrolyte levels (potassium), hemoglobin, and blood cell counts will be conducted. Discontinue use and contact your doctor if shortness of breath or a skin rash develops. Prior to treatment, disclose any history of heart disease, hypertension, seizures, or strokes. Pregnant or breastfeeding individuals, or those planning pregnancy or breastfeeding, should consult their physician regarding its safety.

Primary Ingredients of Zynesp 40 Injection

No information provided. Unable to rephrase.

Uses of Zynesp 40 Injection

Managing anemia associated with chronic kidney failure | Addressing anemia resulting from cancer treatment with chemotherapy

Major Benefits of Zynesp 40 Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Zynesp 40 Injection:

  • Abdominal pain
  • High blood pressure
  • Rash
  • Injection site pain
  • Breathlessness
  • Cough
  • Peripheral edema
  • Procedural hypotension (low blood pressure)
  • Convulsion
  • Thromboembolism

How to use Zynesp 40 Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

How Zynesp 40 Injection works:

Darbepoetin alfa 40 mg Injection boosts red blood cell production. This erythropoiesis-stimulating agent (ESA) acts by prompting the bone marrow to increase its output of red blood cells.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Zynesp 40 Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zynesp 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Zynesp 40 Injection while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Zynesp 40 Injection.

KidneyKidneySAFE IF PRESCRIBED

The administration of Zynesp 40 Injection is considered safe for individuals with renal impairment. No modification to the prescribed dosage of Zynesp 40 Injection is necessary.

LiverLiverCAUTION

For individuals with hepatic impairment, administration of Zynesp 40 Injection requires careful monitoring. Dosage modification of Zynesp 40 Injection may be necessary. Physician consultation is advised.

What if you forget to take Zynesp 40 Injection :

Should you forget a Zynesp 40 Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zynesp 40 Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Type of Treatment KINSHIP
Action Class Erythropoietin-stimulating drug

FAQs on Zynesp 40 Injection

Expect a rise in your red blood cell count (hemoglobin levels) within 2 to 6 weeks of beginning Zynesp 40 Injection. Consult your doctor with any questions.
Zynesp 40 Injection carries a risk of serious side effects, including death, and requires careful administration by a physician experienced with this therapy. Strictly adhere to all prescribed instructions.
Zynesp 40 Injection may be ineffective if you have iron, folic acid, or vitamin B12 deficiencies; these should be addressed. Treatment failure can also result from bleeding, infections, inflammation, or bone marrow fibrosis. Consult your doctor for further evaluation.
Zynesp 40 Injection treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects in children are comparable to those in adults. Consult your doctor for any concerns.
Zynesp 40 Injection can alter blood pressure. Blood pressure monitoring is essential during initial treatment. Patients with hypertension should manage their blood pressure accordingly; the injection may be discontinued if blood pressure remains uncontrolled.
Do not use Zynesp 40 Injection unless prescribed by your doctor. This medication is contraindicated for individuals with uncontrolled hypertension, a history of pure red cell aplasia (PRCA) triggered by Zynesp 40 Injection or similar drugs, or a history of serious allergic reactions to this medicine.
Zynesp 40 Injection
2,408
MRP 2,787
13% off